Buccal Exposure to Human Papillomavirus Type 16 Is a Common Yet Transitory Event of Childhood

Journal of Medical Virology

Volumn 71, Issue 4, 2003, Pages 593-598

  Mant, Christine ^b   Kell, Barbara ^b   Rice, Philip ^b   Best, Jennifer M ^b   Bible, Jon M ^b   Cason, John ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Children; HPV 16; Transient exposure

Indexed keywords

VIRUS DNA;

ARTICLE; CHEEK MUCOSA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY; FEMALE; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; MALE; MOUTH CAVITY; MOUTH INFECTION; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; VIRUS CULTURE; VIRUS INFECTION; WART VIRUS;

CASE-CONTROL STUDIES; CHEEK; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SIBLINGS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0142182239     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10529     Document Type: Article

References (25)

1. Bible JM, Mant C, Best JM, Kell B, Starkey WG, Raju KS, Biswas C, Muir P, Banatvala JE, Cason J. 2000. Cervical lesions are associated with human papillomavirus type 16 intra-typic variants which have high transcriptional activity and increased usage of common mammalian codons. J Gen Virol 81:1517-1527.
2. Biswas C, Kell B, Mant C, Jewers RJ, Cason J, Muir P, Raju KS, Best JM. 1997. Detection of HPV-16 early gene transcription by RT-PCR is associated with abnormal cervical cytology. J Clin Microbiol 35: 1560-1564.
3. Cason J, Kambo PK, Best JM, McCance DJ. 1992. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type 16 in sera from patients with cervical intraepithelial neoplasia and children. Int J Cancer 50:349-355.
4. Cason J, Kaye JN, Jewers RJ, Kambo PK, Bible J, Kell B, Shergill B, Pakarian FB, Raju KS, Best JM. 1995. Perinatal infection and persistence of, human papillomavirus type 16 and -18 in infants. J Med Virol 47:209-218.
5. Cason J, Best JM, Raju KS. 1999. Vertical transmission of human papillomaviruses. Am J Obstet Gynecol 180:774-775.
6. Cavuslu S, Mant C, Starkey WG, Bible JM, Biswas C, Kell B, Rice P, Best JM, Cason J. 1996. Analytic sensitivities of Hybrid Capture, consensus and type-specific PCRs for the detection of human papillomavirus type 16 DNA. J Med Virol 49:319-324.
7. Cavuslu S, Goodlad J, Connor A, Hobbs C, Best JM, Raju KS, Cason J. 1997. Correlation between p53 over-expression and the presence of human papillomavirus DNA in cervical carcinomas and lymph node metastases. J Med Virol 53:111-117.
8. Cubie HA, Plumstead M, Zhang W, de Jesus O, Duncan LA, Stanley MA. 1998. Presence of antibodies to human papillomavirus virus-like particles (VLPs) in 11-13-year-old schoolgirls. J Med Virol 56:210-216.
9. Hamsikova E, Ludvikova V, Smahel M, Sapp M, Vonka V. 1998. Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer 77:689-694.
10. Kaye JN, Pakarian F, Cason J, Jewers RJ, Kell B, Bible J, Raju KS, Best JM. 1994. Viral load as a determinant for the transmission of human papillomavirus type 16 from mother to child. J Med Virol 44:415-421.
11. Kaye JN, Starkey WG, Kell B, Biswas C, Raju KS, Best JM, Cason J. 1996. Human papillomavirus type-16 (HPV-16) in infants: use of DNA sequence analyses to establish the source of infection. J Gen Virol 77:1139-1143.
12. Koch A, Hansen SV, Nielsen NM, Palefsky J, Melbye M. 1997. HPV detection in children prior to sexual debut. Int J Cancer 73: 621-624.
13. Luxton JC, Rose RC, Coletart T, Wilson P, Shepherd PS. 1997. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls. J Gen Virol 78:917-923.
14. Mant C, Kell B, Best JM, Cason J. 1997. Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types -6,-11, -16, -18, -31 & -33. J Virol Methods 66:169-178.
15. Marias D, Rose RC, Williamson A-L. 1997. Age distribution of antibodies to human papillomavirus in children, women with cervical intraepithelial neoplasia and blood donors from South Africa. J Med Virol 51:126-131.
16. Muller M, Viscidi RP, Ulken V, Bavinck JN, Hill PM, Fisher SG, Reid R, Munoz N, Schneider A, Shah KV, et al. 1995. Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population. J Invest Dermatol 104:138-141.
17. Mund K, Han C, Daum R, Helfrich S, Muller M, Fisher SG, Schiller JT, Gissman L. 1997. Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children. Intervirology 40:232-237.
18. Pakarian FB, Kaye J, Cason J, Kell B, Jewers RJ, Raju KS, Best JM. 1994. Cancer associated human papillomaviruses: perinatal transmission, and persistence. Br J Obstet Gynaecol 101:514-517.
19. Puranen M, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S. 1996. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol 174:694-699.
20. Rice PS, Mant C, Cason J, Kell B, Best JM. 2000. High prevalence of human papillomavirus type 16 infection among children. J Med Virol 61:70-75.
21. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH. 2003. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104:336-344.
22. Saiki RA, Bugawan TL, Horn GT, Mullis KB, Erlich HA. 1986. Analysis of enzymatically amplified β-globin and HLA DQ alpha DNA with allele specific oligonucleotide probes. Nature 324:163-166.
23. Sedlacek TV, Lindheim S, Eder C, Hasty L, Woodland M, Ludomirsky A, Rando RF. 1989. Mechanism for human papillomavirus transmission at birth. Am J Obst Gynecol 161:55-59.
24. Silins I, Wang Z, Avall-Lundqvist E, Frankendal B, Vikmanis U, Sapp M, Schiller JT, Dillner J. 1999. Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. J Gen Virol 80:2931-2936.
25. Zur Hausen H. 2001. Oncogenic DNA viruses. Oncogene 20: 7820-7823.